BridgeBio Pharma Inc (BBIO)
26.95
+0.46
(+1.72%)
USD |
NASDAQ |
Dec 23, 10:20
BridgeBio Pharma Total Return Level: 26.50 for Dec. 20, 2024
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Pfizer Inc | 94.13 |
| Alnylam Pharmaceuticals Inc | 245.50 |
| Cassava Sciences Inc | 3.990 |
| Regeneron Pharmaceuticals Inc | 701.85 |
| Vertex Pharmaceuticals Inc | 397.27 |